# Primovist Regulatory Post Marketing Surveillance (PMS)

> **NCT00924248** · — · COMPLETED · sponsor: **Bayer** · enrollment: 4358 (actual)

## Conditions studied

- Liver

## Interventions

- **DRUG:** Gadoxetic acid disodium (Primovist, BAY86-4873)

## Key facts

- **NCT ID:** NCT00924248
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** —
- **Final completion:** 2011-05
- **Target enrollment:** 4358 (ACTUAL)
- **Last updated:** 2012-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00924248

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00924248, "Primovist Regulatory Post Marketing Surveillance (PMS)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00924248. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*